Meeting
Abstract Number: 859
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: An 84-year-old man with stage II non-small cell lung adenocarcinoma had tumor recurrence in the lungs after lobectomy. For first line systemic therapy he was started on pembrolizumab, a monoclonal antibody immune checkpoint inhibitor. Five days after his initial dose, he presented with daily fevers to 39C, progressive weakness, and confusion. He was […]